Raymond James analyst Joseph Altobello maintains Polaris (NYSE:PII) with a Strong Buy and raises the price target from $123 to $130.
Today, 8:15 AM
Mizuho analyst John Baumgartner initiates coverage on General Mills (NYSE:GIS) with a Neutral rating and announces Price Target of $75.
Plus Therapeutics Has Completed Of Enrollment In Cohort 2 Of The Respect-LM Phase 1/2a Dose Escalation Trial Of Rhenium (186Re) Obisbemeda For Leptomeningeal Metastases
Today, 8:13 AM
The company said the next steps, following the Data and Safety Monitoring Board review anticipated next month, will be completing enrollment in Phase 1/Part A, followed by a meeting with the FDA to consider dose
Auddia Has Created A Proprietary Audio Content Hosting And Streaming System To Support The Unique And Exclusive Demands Offered In Its Flagship Mobile App, Faidr
Today, 8:09 AM
The company launched faidrRadio, currently only available in its iOS product, which includes Music Casts and Music Stations on January 24. Music Casts will be added to its Android app later in Q1.
Today, 8:06 AM
Spire (NYSE:SR) reported quarterly earnings of $1.55 per share which beat the analyst consensus estimate of $1.05 by 47.62 percent. This is a 35.96 percent increase over earnings of $1.14 per share from the same period
XORTX Announced Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease
Today, 8:05 AM
- XORTX Therapeutics Inc.
Today, 8:03 AM
We expect our 2023 full-year adjusted diluted EPS to be in a range of $4.98 to $5.13, representing a growth rate of 3% to 6% from an adjusted diluted EPS base of $4.84 in 2022. While the 2023 full-year adjusted diluted
Today, 7:58 AM
Johnson Controls Intl (NYSE:JCI) reported quarterly earnings of $0.67 per share which met the analyst consensus estimate. This is a 24.07 percent increase over earnings of $0.54 per share from the same period last year.